MSICS Pharma

GMP Naturally Sourced Psilocybin Pioneers

Health Tech & Life Sciences
Active
Seed Ness Ziona, Israel Founded 2022
LinkedIn
Last updated 2026-06-18
Total raised
$3.7M
Last: 2026-05
Stage
Seed
Founded
2022
Headcount
12
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences

About

MSICS Pharma, a pioneer in Israel's naturally-sourced Psilocybin production for pharmaceutical use, proudly holds groundbreaking Psilocybin operational licenses. Our innovative GMP production facility is already hard at work, and we're currently navigating a unique approval process, drawing from our successful experience with Cannabis.

Our Psilocybin products are now poised for first-of-a-kind clinical trials with esteemed hospitals, to treat conditions like OCD, Anorexia, PTSD, and depression at first, all within a market valued in the billions of dollars.

We are on track to approve our products as prescribed medicine through a distinctive approval process beginning in Israel, serving as the ideal pharmaceutical beta-site, and extending globally to address unmet medical needs.

Funding history · 3 rounds · $3.7M total

2024-11
Undisclosed
2023-06
$100K

Q&A

What is MSICS Pharma's primary focus?
MSICS Pharma is a pioneer in Israel's naturally-sourced Psilocybin production for pharmaceutical use, holding operational licenses for its GMP production facility.
What conditions do MSICS Pharma's Psilocybin products aim to treat?
MSICS Pharma's Psilocybin products are poised for clinical trials to treat conditions such as OCD, Anorexia, PTSD, and depression.
When was MSICS Pharma founded?
MSICS Pharma was founded in April 2022.
How many employees does MSICS Pharma have?
MSICS Pharma has 11-50 employees.
What is MSICS Pharma's total funding to date?
MSICS Pharma has raised a total of $3,700,000 USD.
When was MSICS Pharma's most recent funding round and who were the investors?
MSICS Pharma's most recent funding round was in May 2026, with investors including Eyal Gura.
What is MSICS Pharma's current product stage?
MSICS Pharma's products are currently in the clinical trial stage.
Who are the co-founders of MSICS Pharma?
The co-founders of MSICS Pharma are Roei Zerahia and Omer Zerahia.

Team · 2

Founder · Co-founder
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & SubstancesRaw Materials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2B2CB2CB2G

Highlights

Verified

Tags

pharmaceuticalsfungimental-health
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)